J.BecherT.El-HagO.KnospeS.GkeB.FischerU
Oral Wegovy (Semaglutide Pill) Approved in December 2025, Oral Wegovy offers semaglutide benefits in pill form, eliminating the need for injections
Another 23% said they remained at a lower weight after stopping the drug
N., Purdy, J., Zheng, I., Pan, C
4 Adverse events in PIONEER 3 1,4 Comparator AE rates are not an adequate basis for comparison of safety between products 1 Because clinical trials are conducted under widely varying conditions, AE rates observed in the clinical trials of a drug cannot be directly compared with rates in the clinical trials of another drug and may not reflect the rates observed in practice 1 AE=adverse event
The exception being lamotrigine, where closer monitoring is advised